Sarah Chesler

Sarah Chesler has a comprehensive work experience in the field of pharmacovigilance and clinical research. Their most recent role is Senior Director of Pharmacovigilance at Acelyrin, Inc. Sarah previously worked at Taysha Gene Therapies as Executive Director and Head of Global Patient Safety, and later as Senior Director and Head of Global Patient Safety. Prior to that, they were Director of Pharmacovigilance at Audentes Therapeutics. Sarah also held various positions at Ultragenyx Pharmaceutical Inc., including Associate Director and Senior Manager of Drug Safety & Pharmacovigilance, as well as Clinical Program Manager. Sarah started their career as a Clinical Project Manager at BioMarin and worked as a Clinical Research Associate at Abbott Laboratories. Sarah began their professional journey as a Clinical Research Nurse at Northwestern University.

Sarah Chesler received their Bachelor of Science in Nursing and Bachelor of Science in Psychology from the University of Wisconsin-Madison between the years 1994 and 2000. Later, between 2008 and 2010, they pursued a Graduate Certificate in Clinical Research & Regulatory Administration from Northwestern University.